Nasdaq composite articles
-
AtriCure (NASDAQ:ATRC) Raised to Outperform at Oppenheimer
Oppenheimer upgraded shares of AtriCure (NASDAQ:ATRC – Free Report) from a market perform rating to an outperform rating in a research report sent to investors on Tuesday morning, Marketbeat.com reports. They currently have $32.00 target price on the medical device company’s stock. Other research analysts have also recently issued reports about the stock. Stifel Nicolaus […]
-
Accolade (NASDAQ:ACCD) Releases Earnings Results
Accolade (NASDAQ:ACCD – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.10) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.01, Briefing.com reports. The firm had revenue of $124.80 million during the quarter, compared to the consensus estimate of $123.91 million. Accolade had a negative net margin […]
-
Geron (NASDAQ:GERN) Shares Up 4.6%
Geron Co. (NASDAQ:GERN – Get Free Report) shares rose 4.6% on Wednesday . The company traded as high as $3.71 and last traded at $3.66. Approximately 2,995,182 shares traded hands during trading, a decline of 73% from the average daily volume of 11,080,196 shares. The stock had previously closed at $3.50. Analyst Ratings Changes A […]